Antimalarial dosing regimens and drug resistance

This publication has 66 references indexed in Scilit:

• The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics
  Malaria Journal, 2007
• Sulfadoxine-pyrimethamine pharmacokinetics in malaria: Pediatric dosing implications
  Clinical Pharmacology & Therapeutics, 2006
• Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison
  The Lancet, 2006
• Quinine Pharmacokinetic-Pharmacodynamic Relationships in Uncomplicated Falciparum Malaria
  Antimicrobial Agents and Chemotherapy, 2003
• Treatment failure of pyrimethamine‐sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya
  Tropical Medicine & International Health, 2003
• The assessment of antimalarial drug efficacy
  Trends in Parasitology, 2002
• Determinants of Treatment Response to Sulfadoxine-Pyrimethamine and Subsequent Transmission Potential in Falciparum Malaria
  American Journal of Epidemiology, 2002
• Clinical Pharmacokinetics and Pharmacodynamics of Artemether-Lumefantrine
  Clinical Pharmacokinetics, 1999
• Effects of artemisinin derivatives on malaria transmissibility
  The Lancet, 1996
• Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993